Evidence map›Paper›PMID 38249822›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2024

COPD in Never-Smokers: BOLD Australia Study.

Marsha A Ivey, Sheree M Smith, Geza Benke, Brett G Toelle, Michael L Hunter, Alan L James, Graeme P Maguire, Richard Wood-Baker, David P Johns, Guy B Marks and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Observational
  2. Review
  3. Observational
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 2 countries.

Marsha A IveySchool of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, 3004, Australia.ORCID 0000-0002-3205-1748
Sheree M SmithSchool of Nursing and Midwifery, Campbelltown Campus, Western Sydney University, Penrith, NSW, 2751, Australia.
Geza BenkeSchool of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, 3004, Australia.
Brett G ToelleRespiratory and Environmental Epidemiology Group, Woolcock Institute of Medical Research, Sydney, NSW, 2037, Australia.
Michael L HunterSchool of Population and Global Health, University of Western Australia, Perth, WA, 6009, Australia.ORCID 0000-0001-6704-4815
Alan L JamesDepartment of Pulmonary Physiology and Sleep Medicine, Sir Charles Gairdner Hospital and Medical School, University of Western Australia, Perth, WA, 6009, Australia.
Graeme P MaguireCurtin Medical School, Curtin University, Perth, WA, 6102, Australia.
Richard Wood-BakerSchool of Medicine, University of Tasmania, Hobart, TAS, 7000, Australia.
David P JohnsMelbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia.
Guy B MarksRespiratory and Environmental Epidemiology Group, Woolcock Institute of Medical Research, Sydney, NSW, 2037, Australia.ORCID 0000-0002-8976-8053
Michael J AbramsonSchool of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, 3004, Australia.ORCID 0000-0002-9954-0538
Monash University · AUThe University of Western Australia · AUWoolcock Institute of Medical Research · AUCurtin University · AUThe University of Melbourne · AUThe University of Queensland · AUUniversity of Tasmania · AUUniversity of the West Indies · TT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Tobacco smoking is the major risk factor for COPD, and it is common for other risk factors in never-smokers to be overlooked. We examined the prevalence of COPD among never-smokers in Australia and identified associated risk factors. Methods: We used data from the Australia Burden of Obstructive Lung Disease (BOLD) study, a cross-section of people aged ≥40 years from six sites. Participants completed interviews and post-bronchodilator spirometry. COPD was primarily defined as an FEV Results: The prevalence of COPD in the 1656 never-smokers who completed the study was 10.5% (95% CI: 9.1-12.1%) [ratio<LLN 4.6%]. The likelihood of having COPD increased with advancing age [odds ratio (OR) 4.11 in those 60-69 years and OR 8.73 in those 70 years and older], having attained up to 12 years of education (OR 1.75) compared to those with more than 12 years, having a history of asthma (OR 2.30), childhood hospitalization due to breathing problems before age 10 years (OR 2.50), or having a family history of respiratory diseases (OR 2.70). Being overweight or obese was associated with reduced prevalence of COPD compared with being normal weight. In males and females, advanced age, a history of asthma, and childhood breathing problems before age 10 were factors that elevated the likelihood of COPD. However, in males, additional factors such as a higher body mass index and a family history of respiratory diseases also contributed to increased odds of COPD. Conclusion: COPD was prevalent in this population of never-smokers aged 40 years and over. This finding highlights the significance of risk factors other than smoking in the development of COPD.

Indexed as

AsthmaPulmonary Disease, Chronic ObstructiveAdultAustraliaChildFemaleHumansMaleMiddle AgedOdds RatioSmokersBOLDburden of obstructive lung diseaseLLNlower limit of normalnon-smokersprevalencespirometry

Identifiers

PMID38249822
PMCPMC10800088
OpenAlexW4390955156

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.